The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
We support a vision of outcomes-driven, sustainable healthcare systems in Europe. We want systems that provide patients with equal and early access to the best and safest medicines; that support innovation while balancing realistically benefit and risk; that empowers citizens to make informed decisions about their health and ensure the highest security of the medicines supply chain. Such a vision will also assist policymakers in sustaining Europe’s economic growth and competitiveness, by balancing healthcare budgets and helping to provide for a healthy and productive workforce. It also offers the most effective approach to deliver the innovative medicines needed to tackle current and potential health threats.
Improving patient outcomes, developing sustainable models of healthcare, reducing inequalities in health, accelerating patients’ access to innovative medicines and improving patient safety – these are our primary commitments. By working in partnership with all healthcare stakeholders, we seek to develop practical solutions to make these goals a reality.
We believe that these commitments are in the best interest of Europe’s citizens. We will engage with all partners in healthcare delivery to discuss, design and implement policies that help us achieve these goals, while improving public health and economic wealth, as well as enhancing Europe’s industrial and science base.
Our Organisational Structure
EFPIA specialised groups
European Biopharmaceutical Enterprises (EBE) represents the voice of biopharmaceutical companies of all sizes in Europe and is a specialised group within EFPIA. Established in 2000, EBE is recognised as the leading biopharmaceutical association in Europe.
Vaccines Europe (VE) is the specialised vaccine industry group within EFPIA. It represents major innovative research-based global vaccine companies as well as small and medium sized enterprises operating in Europe.
EFPIA Partners in Research
The evolving societal and healthcare challenges as well as opportunities offered by new sciences and technologies, call for a much more integrated health research environment than in the past. Responding to the need for integrated cross-sector collaboration in R&D, EFPIA has created "Partners in Research" as a constituent entity open to companies operating in such associated sectors (imaging, MedTech, diagnostics, animal health, IT including e- and m-technologies, contract research organisations, etc.). This membership status makes it possible to jointly design and implement collaborative R&D initiatives in the framework of the Innovative Medicines Initiatives (the largest public private partnership in health research worldwide), which will ultimately implement new R&D, operational and business models that will benefit all sectors involved (impact on R&D processes), patients (new treatment pathways), and society (incentives for reinvestment in areas where there is market failure).
Partners in Research: implementing technology integration
List of current Partners in Research
For further information about Partners in Research, please contact the Science Policy team at email@example.com.